EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma.
J Mol Med (Berl)
; 100(4): 629-643, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35247069
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Extracellular Vesicles
/
Liver Neoplasms
Limits:
Humans
Language:
En
Journal:
J Mol Med (Berl)
Journal subject:
BIOLOGIA MOLECULAR
/
GENETICA MEDICA
Year:
2022
Document type:
Article
Country of publication:
Germany